| Literature DB >> 27622023 |
S Harrison Farber1, Vadim Tsvankin1, Jessica L Narloch2, Grace J Kim2, April K S Salama3, Gordana Vlahovic4, Kimberly L Blackwell2, John P Kirkpatrick2, Peter E Fecci5.
Abstract
Brain metastases represent the most common type of brain tumor. These tumors offer a dismal prognosis and significantly impact quality of life for patients. Their capacity for central nervous system (CNS) invasion is dependent upon induced disruptions to the blood-brain barrier (BBB), alterations to the brain microenvironment, and mechanisms for escaping CNS immunosurveillance. In the emerging era of immunotherapy, understanding how metastases are influenced by the immunologic peculiarities of the CNS will be crucial to forging therapeutic advances. In this review, the immunology of brain metastasis is explored.Entities:
Keywords: Blood–brain barrier; brain metastasis; immune checkpoint blockade; immunotherapy; tumor microenvironment
Year: 2016 PMID: 27622023 PMCID: PMC5006920 DOI: 10.1080/2162402X.2016.1172153
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110